ACTRN12611000719932
已完成
4 期
Impact of Escitalopram and Serotonin Transporter Polymorphisms on Emotion Processing and Regulation In Healthy Participants: A Randomised Controlled Trial
概览
- 阶段
- 4 期
- 干预措施
- 未指定
- 疾病 / 适应症
- Depression
- 发起方
- The University of Sydney
- 入组人数
- 50
- 状态
- 已完成
- 最后更新
- 6年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •Aged 18\-50
- •Caucasian (if recruitment is slow, we will remove this criterion)
- •Fluent in English
排除标准
- •Not on any medication (minimum 1 month drug\-free; with the exception of the contraceptive pill) or illicit drugs.
- •Pregnancy (which will be tested at each visit)
- •Breastfeeding
- •Drug or alcohol addiction
- •A history of brain injury, loss of consciousness, stroke, psychiatric, neurological disorder or other serious medical conditions (e.g., cardiovascular disease and diabetes).
结局指标
主要结局
未指定
相似试验
已完成
4 期
Beta-CIT-SPECT and Neurophysiology in DepressionDepressionNCT00145132Ludwig-Maximilians - University of Munich30
已完成
不适用
The role of the serotonin transporter in citalopram pharmacological MRIserotonine systeemNA10027946NL-OMON42073Academisch Medisch Centrum45
Unknown
早期 1 期
Safety and Efficacy of Escitalopram in the Treatment of Premature EjaculationPremature EjaculationNCT00656552Cairo University100
进行中（未招募）
不适用
Impact of quetiapine prolong and escitalopram on the hypothalamic-pituitary-adrenocortical (HPA)-axis activity in depressed patientsIn this study, patients suffering from unipolar depression are investigated. 40 unipolar depressed inpatients (age 18-65) enter the study after the procedure has been fully explained and written informed consent has been obtained. The patients are diagnosed by experienced and trained psychiatrists according to DSM-IV criteria (296.2, 296.3) using the Structured Clinical Interview for DSM-IV, German version (Wittchen et al. 1997).MedDRA version: 9.1Level: LLTClassification code 10012378Term: DepressionEUCTR2009-011911-19-DEudwig-Maximilian-University of Munich, Department of Psychiatry
已完成
4 期
Brain Effects of Escitalopram and Citalopram Using fMRIAntidepressant Activity in Healthy VolunteersNCT00825825Michael Henry, MD27